Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
11/28/1996 | CA2220415A1 Latent transcripts and promoters of cytomegalovirus |
11/27/1996 | EP0744467A2 Multiple antigenic peptide comprising at least two hepatitis C virus-associated peptides |
11/27/1996 | EP0743983A1 Mammalian thymokine genes |
11/27/1996 | EP0743956A1 Pretargeting methods and compounds |
11/27/1996 | EP0743870A1 Preparation and application of artificial anti-idiotypic imprints |
11/27/1996 | EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
11/27/1996 | CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope |
11/27/1996 | CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor |
11/26/1996 | US5578715 Methods, kits, and probes for diagnosing HIV-2 |
11/26/1996 | US5578714 DNA encoding Duffy 9pd protein |
11/26/1996 | US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases |
11/26/1996 | US5578703 Dimer proteins which bind to transforming growth factor |
11/26/1996 | US5578496 Detection of autoantibodies associated with the disease myasthenia gravis |
11/26/1996 | US5578473 Recombinant negative strand RNA virus |
11/26/1996 | US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
11/26/1996 | US5578448 Polymerase chain reaction |
11/26/1996 | US5578323 Proteinoid carriers and methods for preparation and use thereof |
11/26/1996 | US5578309 For the treatment of candidiasis |
11/26/1996 | US5578308 Glutaraldehyde and formalin detoxified bordetella toxin vaccine |
11/26/1996 | US5578303 Vaccines, t-cells with specificity for heat shock protein 65 |
11/26/1996 | US5578289 Administering antibody-enzyme conjugate |
11/26/1996 | US5578287 Three-step pretargeting methods using improved biotin-active agent |
11/21/1996 | WO1996036713A2 Eck receptor ligands |
11/21/1996 | WO1996036711A2 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
11/21/1996 | WO1996036709A1 Transforming growth factor alpha hii |
11/21/1996 | WO1996036705A1 Viral vectors |
11/21/1996 | WO1996036699A1 Non-pathogenic strains of hiv-1 and methods for detecting same |
11/21/1996 | WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
11/21/1996 | WO1996036366A1 Gene therapy for effector cell regulation |
11/21/1996 | WO1996036359A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies |
11/21/1996 | WO1996036358A1 Compositions and methods for inhibiting xenograft rejection |
11/21/1996 | WO1996036357A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
11/21/1996 | WO1996036356A1 Viral agent associated with mystery swine disease |
11/21/1996 | WO1996036355A1 Leptospira membrane proteins |
11/21/1996 | WO1996036354A2 Anticancer vaccine comprising il6/il6 receptor transfected cells |
11/21/1996 | WO1996036317A1 Production scale method of forming microparticles |
11/21/1996 | WO1996033414A3 Compounds and methods for diagnosis of leishmaniasis |
11/21/1996 | WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection |
11/21/1996 | DE19530272C1 Monoclonal antibody specific for cell-surface glyco-protein MGC-24 |
11/21/1996 | CA2227326A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
11/21/1996 | CA2221350A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies |
11/21/1996 | CA2221305A1 Gene therapy for effector cell regulation |
11/21/1996 | CA2221234A1 Compositions and methods for inhibiting xenograft rejection |
11/21/1996 | CA2220674A1 Leptospira membrane proteins |
11/20/1996 | EP0742903A1 Piperidine analogs and conjugates of procainamide and napa |
11/20/1996 | EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination |
11/20/1996 | EP0742830A1 Fusion proteins that include antibody and nonantibody portions |
11/20/1996 | EP0742829A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
11/20/1996 | EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
11/20/1996 | EP0742795A1 Immuno-stimulatory monoclonal antibodies |
11/20/1996 | EP0742721A1 Methods of prolonged suppression of humoral immunity |
11/20/1996 | EP0550544B1 Antigen-antibody conjugates |
11/20/1996 | EP0542895B1 Cross-reactive influenza a immunization |
11/20/1996 | EP0517895B1 Chimeric chains for receptor-associated signal transduction pathways |
11/20/1996 | EP0174990B2 Immunofixation electrophoresis process |
11/20/1996 | CN1136328A Analog of haemophilus HIN47 with reduced protease activity |
11/20/1996 | CN1136280A Anti-aids secretory recombinant BCG vaccine |
11/19/1996 | US5576421 Recombinant chimeric HIV-1 Gag-Env fusion proteins |
11/19/1996 | US5576175 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
11/19/1996 | US5576003 Ornithobacterium rhinotracheale vaccine and method of immunization |
11/19/1996 | US5576002 Meningococcal polysaccharide conjugate vaccine |
11/19/1996 | US5576000 Envelope protein of hiv with sequences |
11/19/1996 | CA2096315C Human rotaviruses, vaccines and methods |
11/14/1996 | WO1996035787A1 Nucleic acids for treating obesity |
11/14/1996 | WO1996035719A1 Transeptithelial transport of molecular species |
11/14/1996 | WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use |
11/14/1996 | WO1996035710A1 Preparation of immunoglobulin |
11/14/1996 | WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/14/1996 | WO1996035451A1 Novel toxin complex |
11/14/1996 | WO1996035450A1 Diagnostic tests for a new spirochete, borrelia lonestari |
11/14/1996 | WO1996035438A1 Oncogene fusion protein peptide vaccines |
11/14/1996 | WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage |
11/14/1996 | WO1996031186A3 Product and method for preventing respiratory virus infection |
11/14/1996 | CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use |
11/14/1996 | CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/14/1996 | CA2218529A1 Nucleic acids for treating obesity |
11/13/1996 | EP0742229A2 Induction of protection against viral infection |
11/13/1996 | EP0742015A1 Prodrugs for beta-lactamase and uses thereof |
11/13/1996 | EP0742014A1 MHC-peptide labelled conjugates |
11/13/1996 | EP0741869A1 Specific binding substances for antibodies and their use for immunoassays or vaccines |
11/13/1996 | EP0741792A1 Herpesvirus pre-(viral dna replication) enveloped |
11/13/1996 | EP0741789A1 Process for the production of a heterologous protein from a methylotrophic yeast |
11/13/1996 | EP0741788A1 Inducing tolerance with tolerogenic fusion proteins |
11/13/1996 | EP0741787A1 Mammalian expression systems for hepatitis c virus envelope genes |
11/13/1996 | EP0741786A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
11/13/1996 | EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells |
11/13/1996 | EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
11/13/1996 | EP0741745A1 Hepatitis b vaccine |
11/13/1996 | EP0741744A1 Immunogens against gonadotropin releasing hormone |
11/13/1996 | EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy |
11/13/1996 | EP0741578A1 Human growth hormone |
11/13/1996 | EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
11/13/1996 | EP0496787B1 Novel infectious bursal disease virus |
11/13/1996 | EP0480014B1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF |
11/13/1996 | EP0474868B1 Method of producing core structure of retro virus and particle produced thereby |
11/13/1996 | EP0474691B1 Monoclonal antibodies for inducing tolerance |
11/13/1996 | EP0373168B1 Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same |
11/13/1996 | CN1135771A DNA sequence coding for a BMP receptor |
11/13/1996 | CN1135759A Membrane protein polypeptide having functions of supporting pre-B cell growth and gene thereof |
11/13/1996 | CN1135718A Method and products for controlling immune responses in mammals |